本页面由Tiger Trade Technology Pte. Ltd.提供服务

Apellis Pharmaceuticals Inc.

21.64
+0.22001.03%
盘前21.58-0.0600-0.28%05:15 EST
成交量:222.21万
成交额:4,820.45万
市值:27.66亿
市盈率:125.52
高:22.12
开:21.44
低:20.82
收:21.42
52周最高:30.48
52周最低:16.10
股本:1.28亿
流通股本:7,811.99万
量比:0.91
换手率:2.84%
股息:- -
股息率:- -
每股收益(TTM):0.1724
每股收益(LYR):0.1724
净资产收益率:7.48%
总资产收益率:3.53%
市净率:7.47
市盈率(LYR):125.52

数据加载中...

2024/01/22

重要事件披露

Form 8-K - Current report
2024/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/08

重要事件披露

Form 8-K - Current report
2024/01/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/14

重要事件披露

Form 8-K - Current report
2023/12/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities